You are here

Baraclude

U.S. top court rejects hepatitis B drug patent case

Yahoo/Reuters

Mon, 05/4/15 - 09:43 am

Bristol-Myers Squibb

A Decade Old Drug Launch In China With Important Insights Today

Forbes

Wed, 03/18/15 - 10:53 am

Bristol-Myers Squibb

U.S. court invalidates patent on Bristol hepatitis B drug

Reuters

Tue, 02/12/13 - 10:46 am

Bristol-Myers Squibb

Bristol-Myers Squibb: Outstanding Pipeline Makes It Most Attractive Among Large Pharmaceuticals

Seeking Alpha

Fri, 02/25/11 - 12:06 am

Bristol-Myers Squibb

rheumatoid arthritis

chronic myeloid leukemia

BARACLUDE® (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis

Yahoo/Business Wire

Sun, 11/1/09 - 09:13 am